Poehling Capital Management, Inc. Q3 2022 vs. Q4 2022: Insights into Fund Changes

Investors are always curious about what changes occur in their chosen funds. Poehling Capital Management, Inc. recently released a comparison of its 13F holdings between Q3 2022 and Q4 2022. In this blog post, we will delve into the insights that can be gleaned from this comparison and what they might mean for investors.

First, let's take a look at the top five holdings of the fund in Q4 2022: Berkshire Hathaway Class B, Markel Corp, Viatris Inc, Organon & Co, and Apple Inc. It's worth noting that three of the top five holdings, Berkshire Hathaway, Markel Corp, and Apple Inc, were also in the top five holdings in Q3 2022. This retention of top holdings suggests that Poehling Capital Management has confidence in the long-term prospects of these companies.

However, there were a few notable changes in the holdings. ViacomCBS Class B was replaced by ViacomCBS Class A in the top holdings in Q4 2022. This change may indicate that the fund managers believe ViacomCBS Class A has stronger growth potential than its Class B counterpart. Additionally, positions in Medtronic PLC F and Unilever PLC F Sponsored ADR 1 ADR Reps 1 Ord SHS were opened in Q4 2022, indicating that the fund managers believe these companies have growth potential.

Let's examine some of the key shifts in holdings between the two quarters. The biggest increase in holdings was Paramount Global Class B, which saw a 44.8% increase in shares held by the fund. This suggests that the fund managers view Paramount Global Class B as undervalued and poised for growth. In contrast, the biggest decrease in holdings was ProShares Ultra VIX Short-Term ETF, which saw a 67.3% decrease in shares held by the fund. This might suggest that the fund managers are less confident in the near-term prospects for this ETF.

Another notable increase was in holdings of Medtronic PLC F, which saw a staggering 1,655.5% increase in shares held by the fund. This increase is likely due to the fund managers seeing long-term growth potential in the medical device company. The largest decrease was in holdings of Warner Brothers Discovery, which saw a 22.5% decrease in shares held by the fund. This decrease likely reflects the uncertainty surrounding Warner Brothers Discovery, given the current state of the media industry.

In terms of sectors, the biggest increase in holdings was in Financials, which saw a 9.8% increase in shares held by the fund. This increase was likely driven by the performance of the fund's holdings in the Financials sector in Q3 2022. Conversely, the biggest decrease was in Information Technology, which saw a 7.1% decrease in shares held by the fund. This decrease is likely due to the underperformance of the fund's holdings in the Information Technology sector.

In conclusion, the Q3 2022 to Q4 2022 comparison of Poehling Capital Management's 13F holdings provides valuable insights for investors. Despite a few notable changes in the top holdings, the fund managers appear to have confidence in the long-term prospects of some of their top holdings. The increase in holdings of Medtronic PLC F and opening of a position in Unilever PLC F Sponsored ADR 1 ADR Reps 1 Ord SHS suggest that the fund managers see potential in these companies. Additionally, the increase in Financials holdings and decrease in Information Technology holdings reflect the fund managers' assessment of these sectors' performance. All in all, this comparison provides valuable information for investors seeking to understand how Poehling Capital Management's holdings have changed and what that might mean for their investments.